American Association for Cancer Research
00085472can143076-sup-139681_1_supp_0_nls4lq.pptx (3.83 MB)

Supplementary Figures S1-S5 from Leptin–STAT3–G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression

Download (3.83 MB)
posted on 2023-03-30, 23:07 authored by Chao-Ching Chang, Meng-Ju Wu, Jer-Yen Yang, Ignacio G. Camarillo, Chun-Ju Chang

Supplementary Figures S1-S5. Leptin induces STAT3-G9a interaction and their co-occupancy on targeted gene promoters (S1); Leptin induces EMT and stem cell-like traits via down-regulation of miR-200c (S2); STAT3 and G9a expression is required for OBR induction by leptin (S3); Distinct tumor phenotypes in Western obese animals compared to lean animals (S4); STAT3 activation and OBR overexpression in diet-induced obesity rats (S5).



Obesity has been linked to breast cancer progression but the underlying mechanisms remain obscure. Here we report how leptin, an obesity-associated adipokine, regulates a transcriptional pathway to silence a genetic program of epithelial homeostasis in breast cancer stem–like cells (CSC) that promotes malignant progression. Using genome-wide ChIP-seq and RNA expression profiling, we defined a role for activated STAT3 and G9a histone methyltransferase in epigenetic silencing of miR-200c, which promotes the formation of breast CSCs defined by elevated cell surface levels of the leptin receptor (OBRhi). Inhibiting the STAT3/G9a pathway restored expression of miR-200c, which in turn reversed the CSC phenotype to a more differentiated epithelial phenotype. In a rat model of breast cancer driven by diet-induced obesity, STAT3 blockade suppressed the CSC-like OBRhi population and abrogated tumor progression. Together, our results show how targeting STAT3-G9a signaling regulates CSC plasticity during obesity-related breast cancer progression, suggesting a novel therapeutic paradigm to suppress CSC pools and limit breast malignancy. Cancer Res; 75(11); 2375–86. ©2015 AACR.

Usage metrics

    Cancer Research



    Ref. manager